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Current and Future Directions in Frailty Research
Anita Mohandas, MSc,1 JoAnne Reifsnyder, PhD,2 Mimi Jacobs, PT, MPT, GCS,3 and Tim Fox, PT, DPT3
Abstract
The concept of frailty has been evolving dramatically for the past 30 years. Through its evolution, a variety of
single and multidimensional models have been used to describe frailty. This article reviews the current literature
related to the defining dimensions of frailty and identifies the gaps in the literature requiring additional research.
A detailed literature review was performed to identify key dimensions and models currently being used to
define frailty, classify interventions that have been developed to reverse frailty, and identify potential areas for
future research within this field. Despite the large body of research defining the dimensions of frailty, no
consensus exists on a comprehensive, operational definition. A standardized definition will be critical to design
effective interventions at earlier stages along the continuum of frailty and interpret findings from evaluation
studies. Identified gaps in the literature include studies supporting the utility of expanding the definition of
frailty to incorporate social determinants, studies evaluating the role of obesity in the development of frailty, and
the need for longitudinal studies for defining the pathways to developing frailty. This review highlights the need
for an accurate definition of frailty and for longitudinal research to explore the development of frailty and
evaluate the effectiveness of the frailty reversal interventions that may avert or delay adverse outcomes within
this susceptible population. These future research needs are discussed within the context of the growing pres-
sures to bring down health care costs, and the role of comparative effectiveness research and cost-effectiveness
research in identifying interventions with the potential to help slow the growth of health care spending among
the elderly. (Population Health Management 2011;14:277–283)
Introduction
Frailty is characterized by progressive decline in sys-tem function, and affects an estimated 7% of individuals
older than 65 years of age.1 Frailty has not been well defined
and, because it does not present as a syndrome in which
symptoms are easily visualized,2 it is not easily diagnosed.
Although some studies have defined frailty using a single
dimensional approach, others have characterized frailty as a
multidimensional syndrome that encompasses physical, so-
cial, and cognitive attributes.3 To date, a validated definition
of frailty has not emerged, despite years of research on both its
attributes and associated processes.4 There is agreement,
however, on some of the basic signs of frailty, typically in-
cluding the presence of inflammation, sarcopenia, neuroen-
docrine deregulation, and loss of bone density.5 Factors such
as age,1 sex,1 and lifestyle6 have been associated with frailty.
Frailty also is associated with significant debility,1 with frail
older adults having a higher risk for institutionalization,7
hospitalization, and death8 in comparison to non-frail older
adults. Evidence suggests that customized interventions may
reverse some of the physical consequences of frailty.9 How-
ever, our understanding of the effectiveness of current inter-
ventions is limited by the lack of agreement on a standard
definition and the absence of a clearly defined set of determi-
nants, pathways, and outcomes related to frailty. This article
provides an overviewof the current state of frailty research and
identifies gaps in the literature that require additional research.
Methods
A detailed literature review was performed to identify key
dimensions and models currently being used to define
frailty, to classify interventions that have been developed to
reverse frailty, and to identify potential areas for future re-
search within this field. The keywords used for the search
were frailty in combination with models, dimensions, inter-
ventions, and cost-effectiveness.
Results
Dimensions and models related to frailty
As individuals age, a complex set of biological and phys-
ical factors interact to produce a gradual decline in health and
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functional ability.1 These factors combine in different ways,
leading to a variety of pathways that ultimately may
lead to cognitive and functional decline, compromised self-
management capacity, and adverse outcomes such as dis-
ability,1 falls, fractures, hospitalization, institutionalization,7
and mortality.8 This complex and poorly understood web of
frailty causes and associated outcomes is reflected in the
diversity of causal models and approaches to frailty research.
These dimensions and models have focused mainly on
biological, physical, cognitive, and multisystem attributes
related to frailty.
Biological dimensions. Frailty has been hypothesized to
be a process where inflammation, neuroendocrine deregu-
lation, and sarcopenia contribute to a gradual decline in
health.5 Increases in inflammatory markers in older adults
have been associated with both disability and mortality.10,11
For example, high levels of C-reactive proteins and cytokines
that characterize inflammation have been associated with
poorer physical function in older adults.12 Combined with
deficiencies in Vitamin D in the elderly, inflammation may
accelerate the process of developing frailty.13 Puts et al
conducted a prospective cohort study in which frailty was
strongly associated with low levels of 25-hydroxyvitamin D
and moderately increased levels of C-reactive protein. This
was the first study that linked the increase in levels of in-
flammatory markers with indicators related to frailty.14
Furthermore, exercise has been shown to reduce the levels
of inflammatory markers,15 whereas the presence of multiple
chronic diseases is associated with higher levels of such
markers.12 Taken together, these data suggest that factors
typically associated with aging, such as declining levels of
activity and an increasing number of chronic diseases, may
impact biological processes associated with developing
frailty. Biological models of frailty, then, offer the possibility
of quantifiable markers of frailty and suggest that some in-
terventions, such as physical therapy and therapeutic exer-
cise, may impact frailty through multiple pathways.
Physical dimensions and models. The concept of physi-
cal frailty has been studied extensively, which has led to the
development of various approaches to measurement. These
approaches range from single-dimension scales, such as the
assessment of gait speed,16 to multidimensional instruments
such as the Physical Performance Battery (PPB), which in-
cludes gait speed as 1 of 3 measures of function. Gait speed
has been shown to be a highly predictive marker of frailty, as
it is strongly associated with the progressive disability that
characterizes frailty syndrome; furthermore, gait speed has
been shown to be almost as good of a predictor of disability
as the PPB.18 The ease and feasibility of measuring gait
speed in the clinical setting makes it an attractive measure
for many practitioners.4 The multivariate PPB test, on the
other hand, evaluates lower extremity function in the elderly
population using 3 variables: gait speed, repeated chair
stands, and balance tests. This tool has been shown to be
extremely predictive of frailty in the nondisabled elderly
population.18 A study conducted on elderly persons by
Brown et al19 showed that the scores obtained on the PPB
test were significantly associated with measures of strength,
and balance, gait, sensation, and multiple range of motion
values.
In 1998, the concept of frailty as a phenotype was initially
examined by Strawbridge et al utilizing the functional do-
mains model.20 This model defined frailty through the
presence of deficits in 2 or more functional domains, in-
cluding physical, nutritional, cognitive, and sensory func-
tioning. They found that respondents who scored as frail
reported reduced activities, had worse mental health, and
reported lower satisfaction with life. Taking another ap-
proach, Fried et al1 defined frailty as a process whereby a
gradual decline in physiological reserves results in increased
susceptibility to external stressors. Using data from the
Cardiovascular Health Study21 and the Women’s Health and
Aging Study1, Fried et al developed the Fried Index, which
classifies frailty as the presence of at least 3 of 5 criteria:
unintentional weight loss, self-reported exhaustion, grip
strength (weakness), low walking speed, and low physical
activity. They observed that higher scores were associated
with advanced age, African American race, female sex, lower
socioeconomic status, and the presence of comorbidities and
disability. The link between frailty and lower lean body
mass in females is consistent with biological theories. In the
Women’s Health and Aging Study, researchers found that
factors such as exhaustion and weight loss were associated
with a 3 to 5 times greater likelihood of developing frailty.
They concluded that physical weakness is a sign of vulner-
ability for frailty and recommended using outcomes such as
weight loss and exhaustion to identify women who are at
risk for progression into frailty.21
Although these models have shown good predictive value
for identifying both the risk for and presence of frailty, it is
not clear that models focused solely on the physical com-
ponents of frailty are sufficient on their own or whether they
can be improved by using them in conjunction with models
that capture the biological and cognitive aspects of frailty.
Cognitive dimensions. The National Institute on Aging
emphasized the need to understand the role of cognition,
neurodegeneration, and neurological impairment markers in
the development of frailty.22 Studies have reported that some
frail individuals experience cognitive decline. Funes et al23
evaluated whether adding cognitive impairment to the Fried
Criteria would improve its predictive validity. They found
that the population classified as frail according to the Fried
criteria had lower scores on the Mini-Mental State Exam than
did the non-frail and the pre-frail. The frail population with
cognitive impairment was also at higher risk for adverse
outcomes such as disability and hospitalization. Another
observational study reported that independent predictors of
frailty, such as a slow walking speed, in combination with
cognitive impairment, were associated with progression to
dementia.24 Finally, Buchman et al25 showed that increasing
levels of frailty were associated with greater incidence of
Alzheimer’s disease and a more rapid rate of decline in
cognitive function in older persons. Although these studies
show that cognitive impairment is associated with the de-
velopment of frailty, future research using longitudinal
study designs will be necessary to determine whether cog-
nitive impairment is a risk factor for frailty and/or an ad-
verse outcome of frailty.
Multidimensional phenotype. Recognizing that evalua-
tion of impairment of multiple systems is necessary to define
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frailty as a syndrome, Rockwood et al3 posited that frailty is
an accumulation of deficits as captured by symptoms, signs,
disabilities, diseases, and laboratory measurements. They
developed the frailty index (FI), which includes 70 items
derived from a comprehensive geriatric evaluation, the Fol-
stein Mini-Mental State Exam, clinical evaluation, and labo-
ratory tests (eg, HbA1c). Although the 70-item index is a
simple average rate that represents the likelihood of devel-
oping frailty, its use in a clinical setting may not be feasible
because collection of such detailed data is cumbersome for
both clinicians and patients. Therefore, Rockwood and col-
leagues subsequently developed a 7-category Clinical Frailty
Scale that captured fitness level, comorbidities, and func-
tional dependence. This scale identifies populations that
range from robust health to complete dependence on others
based on the subjective judgment of the physician. Valida-
tion studies showed that the shorter scale correlated highly
with the 70-item FI, and performed better than independent
measures of cognition, function, and comorbidities at asses-
sing risk of mortality.26
Comparison of different models. Multiple studies com-
paring these models of frailty in different populations have
been conducted. In a comparison of the FI and Fried Criteria,
Rockwood et al27 found that the measures correlated mod-
erately well in terms of function but less well with cognition.
They found that the FI more robustly predicted combined
risk for adverse outcomes such as institutionalization and all-
cause mortality. Cigolle et al28 compared 3 models of frailty,
which included the FI index, the Fried Criteria, and the
functional domains model. They found that the models
identified discrete groups of frail populations that differed in
their sociodemographic and chronic disease characteristics.
A third of the respondents were classified as frail according
to at least 1 model and there was a 3.1% overlap among all 3
models. Cigolle et al’s results suggest that different models of
frailty may correspond to varying trajectories of frailty that
will ultimately lead to adverse outcomes related to aging.
The results of these comparisons suggest that frailty is a
multidimensional phenotype. Additionally, understanding
and defining the different pathways to develop frailty can
help to provide a more focused definition of different frailty
pathways and enable the design of effective interventions to
prevent or delay the onset of frailty.
Interventions tailored to address frailty
If patients at high risk of frailty could be accurately
identified, then interventions to prevent frailty and/or its
progression could be developed and tested in a target pop-
ulation. However, the lack of consensus in defining frailty as
a syndrome4 has made it difficult to design interventions that
target the populations at greatest risk for frailty. The frail
population is generally deconditioned, sedentary, and
homebound because of the presence of multiple chronic
diseases and their associated disabilities. Targeted interven-
tions could have a significant impact on preventing the
progression of frailty and the negative consequences of
frailty. Physical therapy interventions and therapeutic exer-
cise for the frail population may be a viable option to arrest
the progression of frailty and improve both function and
quality of life.
Studies that evaluate the effectiveness of individualized
home-delivered exercise programs for the elderly population
have found reductions in the risk and incidence of falls and
improvement in physical and emotional function. Teri et al29
conducted a study to evaluate the effectiveness of a 3-month-
long intervention that combined an exercise program with
training the caregiver in behavioral management. This pro-
gram resulted in improvement in physical functioning and
depression scores. The improvements in physical function
were maintained up to 2 years. The subset of patients who
had a high depression score at baseline showed significant
improvements in depression scores that were maintained
up to 24 months.29 Toulette et al30 conducted a study that
evaluated the effect of a 16-week physical training program
on 20 demented elderly people. They demonstrated that
this program resulted in significant improvements in
physical measures such as walking, mobility, flexibility, and
static balance. Gill et al9,31 conducted 2 studies evaluating
the effectiveness of a home-based physical therapy and
occupational therapy program for the physically frail. They
found that at 7 months, the home-based program led to
prevention of functional decline, which was demonstrated
by a 45% reduction in activities of daily living scores in the
intervention group compared to the usual care group.
However, the effects of this program were significant only
for the moderately frail and not for those who were se-
verely frail. In the second study, they showed that among
the subgroup of patients with physical frailty, this same
program led to significant improvements in physical func-
tioning, as measured by instrumental activities of daily
living, mobility, performance-oriented mobility assessment,
and integrated physical performance. Faber et al32 evalu-
ated the effects of moderate-intensity group exercise pro-
grams that were based on either daily mobility activities or
balance exercises in the frail, pre-frail, and non-frail elderly.
Outcomes measured included falls, functional performance,
and disability. They found that the moderate-intensity
group exercise programs had positive effects on falling and
physical performance for the pre-frail, but not the frail el-
derly. Taken together, these results provide strong evidence
that a supervised physical therapy or occupational therapy
rehabilitation program that targets underlying physical
impairments can lead to improvements in physical function
and a reduction in adverse outcomes such as disability
among the elderly. However, the severity of frailty could
have an impact on the effectiveness of the exercise program.
For effective design and evaluation of interventions, priority
must be placed on achieving a consistent definition of
frailty.
Future Directions
Although a large amount of research has been carried out
to study frailty, there are still some gaps in the research that
need to be further addressed. Additionally, emphasis will
need to be placed on research efforts that focus on defining
frailty, as this will be especially important to provide effec-
tive solutions to prevent and delay frailty. This section will
cover the some of the areas of future research, such as at-
tributes that can be used to define frailty, measurement is-
sues related to frailty, methods to improve clinical trial
design for the measurement of frailty, and explore the role of
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comparative effectiveness research (CER) and cost-effective-
ness analysis (CEA) in this area (Table 1).
Conceptualization/Definition: Frailty as a syndrome
Although a significant body of research has focused on
identifying the physical, cognitive, and biological attributes of
frailty, there is no consensus on a standard definition of frailty.
In an effort to reconcile the various perspectives on frailty
measurement, the International Academy on Nutrition and
Aging (IANA) Geriatric Advisory Panel recently reviewed the
findings across studies and populations. The panel concluded
that single dimensions, such as gait speed measured alone or
combined with a PPB, were strongly predictive of frailty.4
They further concluded that disability should be conceptual-
ized as an outcome of frailty rather than being used to identify
frailty. Studies that apply a longitudinal design are needed to
clearly understand development of the syndrome, the out-
comes of frailty, anddifferentiation of outcomes from causes.33
To address some of these gaps in knowledge, Santos–Eggimann
has initiated a longitudinal cohort study to evaluate frailty from
a population-based perspective through the identification of
risk factors (ie, environmental, medical, psychological), and
track the sequence of physical and mental manifestations, tra-
jectories, and transitions between frailty, outcomes related to
disability, and resulting long-term outcomes related to falls and
hospitalization.34 This study may provide crucial information
on the development of frailty. TheAmericanGeriatrics Society/
National Institute on Aging Conference on a Research Agenda
on Frailty in Older Adults brought together clinical experts in
frailty to promote examination of the bodyof research on frailty,
and highlight the need for research on understanding how
specific medical, social, and psychological conditions affect
outcomes related to frailty.
Factors involving individual circumstances (eg, socioeco-
nomic factors) also may play a role in increasing the risk of
developing frailty. For example, Lang et al35 found that older
adults who were poor and resided in deprived neighbor-
hoods had a higher FI than adults who resided in wealthier
neighborhoods. This study demonstrated the need for frailty
models to account for environmental and individual char-
acteristics associated with social settings.
Given that frailty has been associated with decreases in
lean muscle mass and weight loss, overweight individuals
typically have not been viewed as a high-risk population.
However, biological markers linked to frailty, such as C-
reactive proteins, also have been associated with obesity.36
Blaum et al37 evaluated if obesity was associated with the
physical frailty phenotype in an elderly population of
women with a BMI >18.5 kg/m2 and found that women
who were overweight were categorized as pre-frail and ob-
ese women were classified as frail according to the Fried
Criteria. Longitudinal studies will need to be conducted to
disentangle the effects of obesity on frailty development and
to evaluate the effect of weight loss and physical activity on
frailty development in this population.
Measurement: Weighting of factors
The main trend in the development of frailty models has
been evaluation of the trade-off between acquiring precision
within the models and adapting a more broadly defined and
applicable tool for use in clinical settings. In both cases,
weighting of the variables is important because not all risk
factors or predictors increase the risk of developing frailty
equally (eg, terminal illness vs. age-related sarcopenia). Rock-
wood et al26 suggested the use of mathematical techniques,
such as artificial neural networks, to calculate weighted scores
for risk factors. However, clinicians will need to exercise
judgment in conjunction with these scales to identify which
factors increase the risk of developing frailty and to identify
populations forwhom symptoms of frailty could be prevented
or reversed.
The Geriatrics Society/National Institute on Aging con-
ference emphasized the need to identify combinations of traits
or risk factors that contribute to frailty development, which
would improve the targeting of interventions aimed at mod-
ifying particular sets of traits and risk factors.22 Passarino et
al38 carried out a hierarchical cluster analysis in which 2
groups of subjects with different degrees of cognitive, func-
tional, and psychological status were classified into 3 frailty
clusters: non-frail, intermediate, and frail. Their analyses
demonstrated that these 3 clusters correlated with outcomes
such as disability, comorbidity, and 18-month mortality.
Table 1. Summary of Future Directions for Frailty Research
Research Topic Recommended Directions
Conceptualization of frailty * Use of single dimensions such as gait speed alone or along with Physical
Performance Battery for defining frailty
* Use of longitudinal design studies to evaluate determinants and outcomes of frailty
* Role of socioeconomic factors in the development of frailty
* Role of obesity in the development of frailty
Measurement issues * Weighting of risk factors for predicting frailty
Comparison of models * Use of longitudinal designs to compare progression of frailty for different models
Improvement in clinical trial design * Use of screening tools to identify and target populations for interventions
* Use of risk stratification to evaluate severity of frailty
Role of CER and CEA in frailty * Measurement of primary outcomes (eg, ADLs, mobility, performance-based
measures) and secondary outcomes (eg, quality of life, depression) for evaluation of
interventions
* CEA can be added to RCTs for evaluation of interventions from a clinical and an
economic perspective
ADL, activities of daily living; CEA, cost-effectiveness analysis; CER, comparative effectiveness research; RCT, randomized controlled trial.
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They concluded that cluster analysis was a viable method to
differentiate phenotypes and warrants further exploration.
Longitudinal outcomes evaluation for models
When comparing outcomes related to different models,
most studies utilized a cross-sectional sample for cohorts.
Such designs do not allow for an understanding of the pro-
gression of frailty. However, the use of longitudinal cohorts
to identify determinants and outcomes associated with each
of the various models could provide greater insight into
pathways to developing frailty. The results of studies to
differentiate pathways associated with frailty models could
shed more light on refining such models and enable the
design of targeted preventive interventions for populations
identified through different models.
Improvement in designing and conducting trials related
to evaluating interventions targeting frailty
Identifying the ideal population at risk of developing
frailty will be important to recruit effectively for clinical trials
that evaluate interventions that target and prevent frailty.
The Frailty Working Group39 stated that the recruitment
process for these populations may be complex and expen-
sive, and recommended a multistage selection process that
would involve excluding populations who are robust and
identifying a frail subset of the population based on specific
domains of frailty (eg, mobility, muscle strength, nutritional
intake, weight change, balance, endurance, fatigue, physical
activity). The IANA Geriatric Advisory Panel4 concluded
that there is a lack of appropriate screening tools for frailty.
However, the task force recommended that populations that
are 80 years of age or older with subjective fatigue as well as
those younger populations that have the presence of risk
factors (eg, living alone, memory complaints, weight loss,
low walking speed) should be screened. The task force
suggested the use of a case finding tool that includes do-
mains such as fatigue, resistance, ambulation, number of
illnesses, and weight loss.
When designing interventions for the frail populations,
researchers must develop methods to measure the severity of
frailty in populations to evaluate whether interventions will
be effective at different levels of frailty. Gill et al9 found that
individualized interventionswere effective for themoderately
frail but not for the severely frail. Because there are various
models to evaluate frailty, a standardized approach to frailty
staging is needed so that findings from frailty research can be
generalized across different populations. Predictive modeling
techniques could be applied to large data sets to identify
population variation in degree of frailty based on risk fac-
tors.40 The identification of subpopulations at varying levels
of risk could then be followed with a more comprehensive
frailty assessment tool to diagnose frailty and suggest the
primary or secondary interventions to prevent adverse events
at that stage.However, before application of risk stratification,
a standard definition of frailty must be agreed upon.
Role of CER and CEA in designing clinical trials
for frailty
CER has been suggested as an approach to evaluate in-
terventions based on the relative value they provide to pa-
tients. CER could allow for evaluation and comparison of
multiple types of exercise protocols in populations with
varying levels of frailty. However, lack of comparability
among the outcomes measured in current studies makes it
difficult to evaluate which interventions are most effective
for elderly populations. Therefore, standardization of the
outcomes measured in intervention studies is a critical next
step in the frailty research agenda. The Frailty Working
Group39 recommended collecting functional outcomes as
primary end points for this population, such as activities of
daily living, mobility, and performance-based measures.
Secondary outcomes could provide information regarding
the causal pathways between interventions and the devel-
opment of disability. The Working Group suggested the use
of secondary outcomes such as mobility, quality of life, and
depression. These outcomes also could be used to investigate
the effects of interventions on the well-being of frail popu-
lations. Secondary outcomes also could provide insight into
whether changes in performance-based measures actually
translate to meaningful changes in outcomes related to
quality of life. The need to evaluate multiple outcomes, in-
cluding quality of life, is especially important for this pop-
ulation because many frail adults have multiple chronic
diseases and poor function. Outcomes research could reveal
whether provision of interventions at an earlier stage con-
tributes to the delay or prevention of adverse events related
to the development of frailty.
Home health agencies have been reimbursed for their
services and achieved an average profit margin of 16.5% per
year over the last 8 years. Because of the steady growth of
home health services over the last 7 years, along with con-
sistent positive margins for these organizations, in 2006, the
Medicare Commission concluded that home health reim-
bursement payments should be reduced for 2010.41 How-
ever, recent health care reform initiatives have not been
finalized, resulting in uncertainty about future reimburse-
ment. The combined effects of the aging population and in-
creasing chronic illness burden are predicted to increase the
demand for services and support that will allow older adults
to age safely and comfortably at home. In light of the pres-
sures to reduce Medicare expenditures, CEA techniques
could be applied to studies of home-based interventions
targeting frail older adults to identify interventions with the
greatest value (ie, those that are the lowest cost and most
effective when applied to the target population). CEA stud-
ies will need to measure effectiveness with respect to both
short-term intermediate outcomes, such as improvement of
physical function and reduction in functional decline, and
long-term outcomes such as falls and mortality. A study by
Jutkowitz et al42 evaluated the cost-effectiveness of a physi-
cal therapy and occupational therapy intervention to prevent
functional decline in an elderly population through mea-
surement of functional difficulties and costs. They showed
that this intervention was cost-effective when compared to
usual care. CEA could be added to randomized controlled
studies to evaluate frailty interventions from a clinical and an
economic perspective. However, to conduct meaningful CEA
studies, there will need to be more clarity in defining out-
comes related to different frailty models. Consensus work-
shops could be useful to determine appropriate end points




Frailty research has evolved dramatically over the last 30
years, producing new insights into both the definition and
measurement of determinants and outcomes. This review
provides a summary of the current state of frailty research.
Specifically, it describes frailty models, identifies gaps in
research, and makes recommendations to improve research
in this arena. Although a large body of research has focused
on defining the dimensions of frailty, there still is no agree-
ment on a comprehensive operational definition of frailty.
However, a standardized definition of frailty is critical to
design effective interventions at earlier stages along the
frailty continuum and to interpret findings across studies.4
The care of the elderly who frequently have multiple co-
morbidities accounts for the greatest portion of current
health care spending. Interventions that would prevent or
delay adverse outcomes such as disability, institutionaliza-
tion, and mortality for this susceptible population may in-
crease function and quality of life while at the same time
potentially decreasing health care spending. Research on
interventions to reverse and delay frailty will play an im-
portant role in promoting healthy and active aging.
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